Clinical research

Open public recruiting

 ID  Research title Principal Investigator
Research Secretariat
Target
diseases
symptom
Status UMIN* Remarks
JORTC
-PAL16
International, multi-centre, double-blind, dose increment, parallel-arm, randomised controlled of duloxetine versus pregabalin over 14 days for opioid unresponsive cancer-related neuropathic pain Principal Investigator
/Research Secretariat:
Hiromichi Matsuoka
Kindai University Faculty of Medicine
Neuropathic Cancer Pain Open
public
recruiting
jRCTs
051190097
JORTC
-KMP03
Efficacy of Rikkunshito on Chemotherapy-Induced Nausea and Vomiting in Patients with Uterine Corpus or Cervical Cancer Treated with Cisplatin-Based Regimen -Placebo-Controlled, Double-Blind, Randomized Confirmatory Study (Efficacy of Rikkunshito on Chemotherapy-Induced Nausea and Vomiting) Principal Investigator:
Hidemichi Watari
Hokkaido University Hospital

Research Secretariat:
Shunsuke Onishi
Hokkaido University Hospital
Uterine cervical
Corpus cancer
Open
public
recruiting
jRCT
1011190007
Japan Agency for Medical Research and Development
PhaseR PHarmacological Audit study of Safety and Effectiveness in Real world (Phase R): Opioid for Cancer Dyspnea Study Principal Investigator
/Research Secretariat:
Takashi Yamaguchi
Konan medical center
Cancer dyspnea Open
public
recruiting
UMIN
000038918
JORTC
-PAL19
Cross-sectional research of interaction and causal relationship among factors related to dyspnea in patients with cancer Principal Investigator
/Research Secretariat:
Yoshinobu Matsuda
National Hospital Organization Kinki-Chuo Chest Medical Center
Cancer Open
public
recruiting
UMIN
000038820
JORTC
-ONC10
LANDMARC
The Comprehensive Multi Center Survey on Sexual Dysfunction following Conventional Laparoscopic and Modern Minimally Invasive Approaches for Rectal Cancer (the LANDMARC Study) Principal Investigator:
Yasushi Rino

Research Secretariat:
Masakatsu Numata
Rectal Cancer Open
public
recruiting
UMIN
000037298
JORTC
-RHB02
A study to confirm the efficacy of specialized rehabilitation for cancer patients in palliative care units; A multi-center randomized controlled trial Principal Investigator
/Research Secretariat:
Nanako Nishiyama
Cancer Open
public
recruiting
UMIN
000037298
Japan Agency for Medical Research and Development
JORTC
-PAL15
Randomized, placebo-controlled phase II study of efficacy of morphine for dyspnea in patients with interstitial lung disease: JORTC-PAL15 Principal Investigator
/Research Secretariat:
Yoshinobu Matsuda
National Hospital Organization Kinki-Chuo Chest Medical Center
Interstitial lung disease Open
public
recruiting
jRCTs
051190030
JORTC
-ONC05
(PIT-3)
A phase II trial of induction erlotinib followed by surgical resection in patients with pathologically confirmed stage IIIA-N2 EGFR mutated non-small cell lung cancer. Principal Investigator:
Morihito Okada
Hiroshima University
Research Secretariat:
Kazuya Takamochi
Juntendo University
Stage IIIA-N2 EGFR mutated, Non-small cell lung cancer Open
public
recruiting
UMIN
000026197
JORTC
-CAM04
Efficacy of Oral AHCC Supplementation in Female Breast Cancer Patients undergoing Anthracycline or Taxan-based Anticancer Drug: Randomized, Double-blind, Placebo controlled Confirmatory study Principal Investigator
/Research Secretariat:
Reo Hamaguchi
Nagumo Clinic Tokyo
Breast Neoplasms Open
public
recruiting
jRCTs
031180324
Amino Up
Co., Ltd.
JORTC
-SUP03
The development of new preventive measures and therapeutic methods in the management of hand-foot syndrome by multi-kinase inhibitors regorafenib (PMTMHFS) Principal Investigator
/Research Secretariat:
Aya Nishizawa
Japanese Foundation For Cancer Research
Colorectal cancer Open
public
recruiting
jRCTs
031180096
JORTC
-ONC07
Colonic stent for "Bridge to Surgery" prospective randomized controlled trial comparing treatment with non-stenting surgery in stage II/III obstructive colon cancer. Principal Investigator:
Yoshihisa Saida
Toho University Ohashi Medical Center

Research Secretariat:
Shuntaro Yoshida
University of Tokyo
Colorectal cancer Open
public
recruiting
UMIN
000026158

Preinitiation

------


Completion of registration

 ID  Research title Principal Investigator
Research Secretariat
Target
diseases
symptom
Status UMIN* Remarks
JORTC
-GRT01
Development of a communication robot system realizing prevention of severe frailty of elderly living alone   Frail or pre-Frail elderly completion
of
registration
UMIN
000036341
Japan Agency for Medical Research and Development
JORTC
-ONC02
(PIT-1)
A randomized phaseⅡ trial of induction CDDP + PEM + BEV versus CDDP + PEM with concurrent radiotherapy followed by surgical resection in patients with pathologically confirmed stage ⅢA-N2 non-squamous-cell non-small cell lung cancer.(Personalized Induction Therapy Clinical Trial-1, PIT-1) Principal Investigator:
Morihito Okada
Hiroshima University

Research Secretariat:
Kazuya Takamochi
Juntendo University Hospital
Stage ⅢA-N2 non-squamous-cell non-small cell lung cancer completion
of
registration
UMIN
000011941
JORTC
-ONC03
(PIT-2)
A phase II trial of induction CDDP plus TS-1 with concurrent radiotherapy followed by surgical resection in patients with pathologically confirmed stage IIIA-N2 squamous-cell non-small cell lung cancer. Principal Investigator:
Kenji Suzuki
Juntendo University Hospital
Research Secretariat:
Kazuya Takamochi
Juntendo University Hospital
Stage IIIA-N2 Squamous, Non-small cell lung cancer completion
of
registration
jRCTs
031180403
JORTC
-ONC04
(CRES3T)
A multicentre,single arm,confirmatory trial to evaluate the effectiveness of induction CDDP plus TS-1 with concurrent radiotherapy(66Gy) followed by surgical resection in patients with superior sulcus tumor Principal Investigator:
Masahiro Tsuboi, M.D.,Ph.D.
National Cancer Center Hospital East

Research Secretariat:
Kazuya Takamochi, M.D.,Ph.D.
Juntendo University
Superior sulcus tumor completion
of
registration
UMIN
000014386
National Cancer Center Research and Development Fund

* jRCT(Japan Registry of Clinical Trials)臨床研究実施計画・研究概要公開システム。このシステムは、医療機関等で実施される臨床研究について、「臨床研究法」及び「再生医療等の安全性の確保等に関する法律」の規定に基づき、厚生労働大臣に対して、実施計画の提出などの届出手続を行うためのシステムです。また、同法に規定する臨床研究実施基準に基づき、世界保健機関(WHO)が公表を求める事項や研究過程の透明性確保及び国民の臨床研究への参加の選択に資する情報について公開しています。
https://jrct.niph.go.jp/

* UMIN CTR is a Japanese clinical trial registration system operated by UMIN (University hospital Medical Information Network). UMIN CTR is approved by ICMJE (International Committee of Medical journal Editors).
http://www.umin.ac.jp/ctr/index-j.htm



Published:2012.12.03
Last updated:2020.04.23

 
 

This site complies with the HONcode standard for trustworthy health information: verify here.